NASDAQ · YMT

Yimutian Inc.. American

$0.34 +$0.04 (+12.17%) 1D After hours

Key Metrics

$2.28M
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow −$7.15M
Beta · 1Y 0.96
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 24
    From its Feb 2 high, the share price fell 99%.

    Peak close $27.39 on Feb 2; trough close $0.30 on Jul 24. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -99%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 20
    The stock moved -44.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 20
  • Mar 25
    The stock moved -35.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 25

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.28M
Enterprise value
Shares outstanding7.6M
52-wk range$0.27 – $33.30
Avg volume · 20D350.4K
Net cash
Book value / share$-3.59
ExchangeNASDAQ
About Yimutian Inc.. American
IPO dateAug 19, 2025
Employees673

Yimutian Inc operates an agricultural B2B platform in China. It provides a comprehensive set of digital solutions to facilitate agricultural product transactions, ranging from searching and matching to transaction facilitation and settlement, through its Yimutian App and Douniu App.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio0.50
Quick ratio0.49
Debt / equity
Debt / EBITDA
Net cash
Working capital−$22.27M

Cash Flow · TTM

Operating CF −$7.03M
Capex −$122.00K
Free cash flow −$7.15M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

Needs two fiscal years of filings

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings